GNE-9815
≥98%
- Product Code: 100702
CAS:
2729996-45-4
| Molecular Weight: | 455.59 g./mol | Molecular Formula: | C₂₆H₂₂FN₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
GNE-9815 is primarily utilized in the field of oncology research, where it serves as a potent and selective inhibitor targeting specific kinases involved in cancer cell proliferation and survival. Its application is focused on preclinical studies to evaluate its efficacy in inhibiting tumor growth and understanding its mechanism of action in various cancer models. Researchers employ GNE-9815 to explore its potential as a therapeutic agent, particularly in cancers driven by dysregulated kinase signaling pathways. Additionally, it is used in combination studies with other anticancer agents to assess synergistic effects and enhance treatment outcomes. The compound also aids in the development of biomarkers to predict patient response and resistance mechanisms, contributing to personalized medicine approaches in oncology.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft436,351.37 |
+
-
|
GNE-9815
GNE-9815 is primarily utilized in the field of oncology research, where it serves as a potent and selective inhibitor targeting specific kinases involved in cancer cell proliferation and survival. Its application is focused on preclinical studies to evaluate its efficacy in inhibiting tumor growth and understanding its mechanism of action in various cancer models. Researchers employ GNE-9815 to explore its potential as a therapeutic agent, particularly in cancers driven by dysregulated kinase signaling pathways. Additionally, it is used in combination studies with other anticancer agents to assess synergistic effects and enhance treatment outcomes. The compound also aids in the development of biomarkers to predict patient response and resistance mechanisms, contributing to personalized medicine approaches in oncology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :